25Feb/13

Data Demonstrating the Safety and Efficacy of Chimerix's Antiviral CMX001 … – PharmaLive (press release) (subscription)

Data Demonstrating the Safety and Efficacy of Chimerix’s Antiviral CMX001
PharmaLive (press release) (subscription)
No evidence of CMX001-associated kidney toxicity was seen in stem cell transplant recipients who were enrolled in a 230-patient Phase 2 study to evaluate CMX001 for prevention of cytomegalovirus (CMV) infection. Subjects on CMX001 had stable to